Holders — by stockHoldings — by fund
GordonMD Global Investments LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0002039349
$166.5M
disclosed book value
14
positions
21.8%
largest position share
Positions, as of 2026-09-30
top 14 of 14 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | PYXSPYXIS ONCOLOGY INC | 15.5M | $36.2M | 21.8% |
| 2 | KYTXKYVERNA THERAPEUTICS INC | 4.5M | $30.7M | 18.5% |
| 3 | TEVATEVA PHARMACEUTICAL INDS LTD | 379,520 | $15.0M | 9% |
| 4 | CLDXCELLDEX THERAPEUTICS INC NEW | 279,720 | $9.1M | 5.4% |
| 5 | TNGXTANGO THERAPEUTICS INC | 1.9M | $9.0M | 5.4% |
| 6 | VIRVIR BIOTECHNOLOGY INC | 803,552 | $9.0M | 5.4% |
| 7 | ADRXADARX PHARMACEUTICALS INC | 450,000 | $9.0M | 5.4% |
| 8 | ALLOALLOGENE THERAPEUTICS INC | 5.3M | $8.5M | 5.1% |
| 9 | BLCOBAUSCH PLUS LOMB CORP | 475,472 | $8.1M | 4.9% |
| 10 | EDITEDITAS MEDICINE INC | 3.1M | $8.0M | 4.8% |
| 11 | INCYINCYTE CORP | 51,080 | $6.2M | 3.7% |
| 12 | TSHATAYSHA GENE THERAPIES INC | 248,000 | $6.2M | 3.7% |
| 13 | AMGNAMGEN INC | 14,512 | $6.1M | 3.7% |
| 14 | SRRKSCHOLAR ROCK HLDG CORP | 110,500 | $5.3M | 3.2% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.